Moreover, it has been shown that the EP score provided prognostic information on the risk of distant metastasis of breast cancer patients beyond clinic-pathological parameters such as ki-67 and quantitative ER immunohistochemistry[1]. The gene discussed is ESR1; the disease is breast carcinoma.